Chordia Therapeutics Inc. (JP:190A) has released an update.
Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Chordia Therapeutics Inc. is committed to launching innovative drugs with novel mechanisms of action, aiming for sustainable sales and growth. The company emphasizes strong corporate governance to enhance trust and adapt to changing business environments, with Takeda Pharmaceutical Company Limited as its largest shareholder. Despite being a small player in the pharmaceutical sector, Chordia is listed on the Growth Market and is focused on strengthening its organizational structure for long-term success.
For further insights into JP:190A stock, check out TipRanks’ Stock Analysis page.